When a peptide vendor displays a Certificate of Analysis (COA) with a "verified" badge or a clickable portal link, it signals that the document was issued by a third-party laboratory rather than produced in-house. That part is real. But "verified" covers a narrow technical act: confirmation that a report with a given reference number exists in a lab's own database. It says nothing about several things buyers often assume it does.
What Report Verification Actually Does
Independent testing labs such as Janoshik operate publicly accessible verification portals (Janoshik's is at verify.janoshik.com) where anyone can enter a report's unique key and confirm that the lab did issue a document with that identifier. The check answers one question. Is this report in our system? A positive result rules out the most straightforward form of fraud, where a vendor fabricates a document from scratch and attaches a realistic-looking lab name and number.
Labs that publish verification portals usually display the core findings tied to that reference number too: compound name, reported purity percentage, and the analytical method used. That method is commonly HPLC (High-Performance Liquid Chromatography) for purity, and MS or mass spectrometry for identity confirmation. Some portals also show the sample submission or testing date, plus the client name or order number.
What Verification Does Not Prove
Portal verification confirms the report is real. It does not confirm:
| Question | What verification says |
|---|---|
| Was the sample submitted by this vendor? | Unknown — any party can submit under any label |
| Does the vial you received match the tested sample? | Not addressed |
| Was the sample cherry-picked from a batch? | Not addressed |
| Is the compound free of biological contaminants (endotoxins, sterility)? | Only if those specific tests appear on the COA |
| Is the compound appropriate for human use? | Not addressed — research peptides are sold for research use, not approved for human consumption |
The biggest gap is chain of custody. A COA is issued on a sample the lab received. By design, it cannot certify that the product in a customer's order came from the same production lot. Independent aggregator sites such as Peptigrity publish the raw data as submitted, with the original COA images attached. They do not audit the vendor's fulfillment process.
A second gap involves test scope. HPLC purity readings measure the proportion of the target peptide peak relative to total detected peaks in a solution. A sample can read 99% purity by HPLC while still carrying endotoxins, residual solvents, or microbial contamination that an HPLC purity run does not detect. So before treating a purity figure as a full safety profile, check whether the COA includes supplementary panels: LAL endotoxin testing, residual solvent analysis (the relevant pharmacopoeial chapter is USP <467>), or microbial limits.
How to Read a COA More Critically
Some community projects go beyond republishing vendor COAs and commission their own independent tests. VialAudit describes a model in which it places anonymous test orders under an alias, ships the vials to rotating third-party labs blind to the vendor, and publishes what the chromatograms show; as of early 2026 the project describes itself as in its first audit cycle. Larger independent datasets already exist. Finnrick reports having run several thousand independent tests across a few hundred vendors, and review aggregators such as PeptideBenchmark compile those results into vendor comparisons. Where an independent test diverges from a vendor's own documentation, you can see that discrepancy directly. It is a stronger basis for assessing consistency than portal verification alone.
Pharmacopoeial bodies including USP and the European Pharmacopoeia (Ph. Eur.), published by EDQM (Council of Europe), publish reference standards and method guidance for peptide characterisation; USP's published work on reference standards for synthetic peptide therapeutics is one example. Pharmaceutical-grade manufacturers and CDMOs such as Bachem and PolyPeptide operate under GMP and publish technical documentation on their quality systems. Research-grade vendors operate under different regulatory frameworks and are not held to the same standards. Verification portals do not surface that distinction.
When reading any COA, the most informative questions are: which tests were run, by which method, on which date, and who submitted the sample? Portal verification answers the last part only partially. The rest requires reading the document itself.